Eudaimonia Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $1.58M | Buy |
2,035
+4
| +0.2% | +$3.11K | 0.84% | 33 |
|
|
2023
Q4 | $1.18M | Buy |
2,031
+100
| +5% | +$58.3K | 0.77% | 40 |
|
|
2023
Q3 | $1.04M | Buy |
1,931
+5
| +0.3% | +$2.69K | 0.73% | 40 |
|
|
2023
Q2 | $903K | Hold |
1,926
| – | – | 0.61% | 46 |
|
|
2023
Q1 | $661K | Buy |
1,926
+11
| +0.6% | +$3.78K | 0.45% | 66 |
|
|
2022
Q4 | $701K | Buy |
1,915
+368
| +24% | +$135K | 0.47% | 58 |
|
|
2022
Q3 | $500K | Buy |
1,547
+25
| +2% | +$8.08K | 0.34% | 77 |
|
|
2022
Q2 | $493K | Buy |
1,522
+770
| +102% | +$249K | 0.34% | 82 |
|
|
2022
Q1 | $215K | Buy |
+752
| New | +$215K | 0.12% | 158 |
|